Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation ESC 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Presenter: Borja Ibanez

August 30, 2025

Presentation THT 2025

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Presenter: Qianlan Xi

February 12, 2025

Presentation THT 2025

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Presenter: Andreas Schafer

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT Abstracts 2025

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

February 11, 2025

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

Presentation THT 2024

The Pivotal ALIVE Trial of the Revivent TC Transcatheter Ventricular Enhancement System in Heart Failure Patients with Prior Anterior Myocardial Infarction

Presenter: Jerry D. Estep

March 05, 2024

Presentation TCT 2023

TCT 479: A Propensity-Matched Analysis of Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction: Insights From the Netherlands.

Presenter: Margriet Bogerd

October 25, 2023

Presentation TCT 2023

TCT 371: C-reactive protein apheresis in cardiogenic shock – case series from the C-reactive protein apheresis in the Acute Myocardial Infarction-Registry (CAMI-R)

Presenter: Jan Torzewski

October 25, 2023

Presentation TCT 2023

TCT 995: Emergency ECpella for ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Presenter: Giuseppe Ferrante

October 24, 2023

Presentation TCT 2023

TCT 991: A Case of Extracorporeal Membrane Oxygenation use in Acute Myocardial Infarction Associated Right Ventricular Failure

Presenter: Ankur Dalsania

October 24, 2023

Presentation THT 2023

The Cardiogenic Shock Team in Acute Myocardial Infarction Cardiogenic Shock: A Crew Resource Management Approach

Presenter: Mark Jacobs

March 21, 2023

Presentation THT 2023

Impact of ST Elevation Myocardial Infarction (STEMI) on patients with chronic heart failure: A National Analysis

Presenter: Dhairya Nanavaty

March 20, 2023

Presentation ESC 2022

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Presenter: Otavio Berwanger

August 29, 2022

Presentation THT 2022

Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO In Acute Myocardial Infarction

Presenter: Kay Everett

February 01, 2022

Presentation TCT Abstracts Posters 2019

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Presenter: Jihoon Kim

October 03, 2019

Presentation TCT 2018

Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study

Presenter: Ulrich P. Jorde, John M. Lasala, Christoph Garlichs

September 21, 2018

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation

Atherosclerotic Burden and Heart FailureAfter Myocardial Infarction

Presenter: Yariv Gerber

March 31, 2016

Advertisement

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

The Pivotal ALIVE Trial of the Revivent TC Transcatheter Ventricular Enhancement System in Heart Failure Patients with Prior Anterior Myocardial Infarction

TCT 479: A Propensity-Matched Analysis of Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction: Insights From the Netherlands.

TCT 371: C-reactive protein apheresis in cardiogenic shock – case series from the C-reactive protein apheresis in the Acute Myocardial Infarction-Registry (CAMI-R)

TCT 995: Emergency ECpella for ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

TCT 991: A Case of Extracorporeal Membrane Oxygenation use in Acute Myocardial Infarction Associated Right Ventricular Failure

The Cardiogenic Shock Team in Acute Myocardial Infarction Cardiogenic Shock: A Crew Resource Management Approach

Impact of ST Elevation Myocardial Infarction (STEMI) on patients with chronic heart failure: A National Analysis

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO In Acute Myocardial Infarction

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Atherosclerotic Burden and Heart FailureAfter Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content